Market Research Logo

Interventional Neurology Devices - Medical Devices Pipeline Assessment, 2018

Interventional Neurology Devices - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Interventional Neurology Devices - Medical Devices Pipeline Assessment, 2018 provides an overview of Interventional Neurology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Interventional Neurology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Interventional Neurology Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Interventional Neurology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Interventional Neurology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Interventional Neurology Devices Overview
3 Products under Development
3.1 Interventional Neurology Devices - Pipeline Products by Stage of Development
3.2 Interventional Neurology Devices - Pipeline Products by Segment
3.3 Interventional Neurology Devices - Pipeline Products by Territory
3.4 Interventional Neurology Devices - Pipeline Products by Regulatory Path
3.5 Interventional Neurology Devices - Pipeline Products by Estimated Approval Date
3.6 Interventional Neurology Devices - Ongoing Clinical Trials
4 Interventional Neurology Devices - Pipeline Products under Development by Companies
4.1 Interventional Neurology Devices Companies - Pipeline Products by Stage of Development
4.2 Interventional Neurology Devices - Pipeline Products by Stage of Development
5 Interventional Neurology Devices Companies and Product Overview
5.1 Alcyone Lifesciences Inc Company Overview
5.2 Amnis Therapeutics Ltd Company Overview
5.3 Anaconda BioMed SL Company Overview
5.4 Aneuclose LLC Company Overview
5.5 Aneuvas Technologies Inc Company Overview
5.6 Apeliotus Technologies Company Overview
5.7 Arterain Medical Inc (Inactive) Company Overview
5.8 Avantec Vascular Corp Company Overview
5.9 Bendit Technologies Ltd Company Overview
5.10 BioCure Inc Company Overview
5.11 Cardiatis SA Company Overview
5.12 Ceretrieve Ltd Company Overview
5.13 Cerus Endovascular Ltd Company Overview
5.14 Codman & Shurtleff Inc Company Overview
5.15 Collagen Matrix Inc Company Overview
5.16 CranioVation Company Overview
5.17 CVTec Cerebrovascular Technologies GmbH Company Overview
5.18 Dartmouth College Company Overview
5.19 DePuy Synthes Inc Company Overview
5.20 EchoGuide Medical, Inc. (Inactive) Company Overview
5.21 Ecole Polytechnique Federale de Lausanne Company Overview
5.22 Evasc Medical Systems Corp Company Overview
5.23 Gaudi Vascular, Inc. Company Overview
5.24 Hansen Medical Inc Company Overview
5.25 Hibernia Medical Company Overview
5.26 Insera Therapeutics, LLC Company Overview
5.27 InspireMD Inc Company Overview
5.28 Instent SAS Company Overview
5.29 Medikit Co Ltd Company Overview
5.30 Medtronic plc Company Overview
5.31 Merlin MD Pte. Ltd. Company Overview
5.32 Metactive Medical LLC Company Overview
5.33 MicroPort Scientific Corp Company Overview
5.34 MicroVention Inc Company Overview
5.35 MindFrame Inc Company Overview
5.36 MRI Interventions Inc Company Overview
5.37 NEOS Surgery SL Company Overview
5.38 Neuravi Ltd Company Overview
5.39 NeuroInterventional Therapeutics, Inc. Company Overview
5.40 NeuroInterventions Company Overview
5.41 Neurosigma Inc Company Overview
5.42 Neurosyntec LLC. (Inactive) Company Overview
5.43 NexGen Medical Systems Inc Company Overview
5.44 Novasentis Inc Company Overview
5.45 NSVascular, Inc. Company Overview
5.46 Oxford Endovascular Ltd Company Overview
5.47 Palmaz Scientific Inc (Inactive) Company Overview
5.48 PhotoThera Inc (Inactive) Company Overview
5.49 Pulse Therapeutics Inc Company Overview
5.50 Qvanteq AG Company Overview
5.51 Rapid Medical Company Overview
5.52 Rontis AG Company Overview
5.53 Shape Memory Therapeutics, Inc. Company Overview
5.54 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.55 Stryker Corp Company Overview
5.56 Taewoong Medical Co Ltd Company Overview
5.57 Transverse Medical Inc Company Overview
5.58 Triticum Medical Ltd. Company Overview
5.59 Twin Star Medical Inc Company Overview
5.60 University of California Los Angeles Company Overview
5.61 University of California San Francisco Company Overview
5.62 University of Minnesota Company Overview
5.63 University of South Florida Company Overview
5.64 University of Wisconsin Madison Company Overview
5.65 University of Wolverhampton Company Overview
5.66 Vascular Solutions Inc Company Overview
5.67 Viket Medical Corporation Company Overview
5.68 Voyager Therapeutics, Inc. Company Overview
5.69 Weill Cornell Medical College Company Overview
5.70 Zoll Medical Corporation Company Overview
6 Interventional Neurology Devices- Recent Developments
6.1 May 16, 2018: Rapid Medical: First Patient Enrolled to the TIGER Pivotal Clinical Study
6.2 May 15, 2018: BTG: Final Results For year ended 31 March 2018
6.3 May 15, 2018: MRI Interventions Announces First Quarter 2018 Results
6.4 May 14, 2018: Parker Waichman is Investigating Potential Neurovascular Stent Claims Following Recent FDA Safety Alert
6.5 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.6 May 10, 2018: Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights
6.7 May 08, 2018: Penumbra Reports First Quarter 2018 Financial Results
6.8 May 07, 2018: Stryker''s Trevo Retriever becomes first and only device indicated for acute ischemic stroke treatment up to 24 hours in Europe
6.9 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.10 Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results
6.11 Apr 26, 2018: Stryker reports first quarter 2018 operating results
6.12 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results
6.13 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.14 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.15 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results
6.16 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.17 Mar 29, 2018: MicroPort Vertebral Artery Rapamycin Target Eluting Stent System Granted CFDA Green-Path
6.18 Mar 29, 2018: MIVI Neuroscience Begins European Commercialization After Achieving CE Mark Approval Of The R4Q Revascularization Catheter For Ischemic Stroke
6.19 Mar 28, 2018: Tubridge Gains CFDA Approval
6.20 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results
6.21 Mar 27, 2018: MicroPort Scientific Announces Year Ended 31 December 2017 Financial Results
6.22 Mar 26, 2018: Silk Road Medical Names Donald J. Zurbay to Board of Directors
6.23 Mar 21, 2018: Collagen Matrix Names Gregory Pomrink as Vice President, Research and Development
6.24 Mar 20, 2018: Balt USA Announces 510(k) Clearance of the Optima Coil System and New Balt USA Headquarters
6.25 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson
6.26 Mar 15, 2018: MRI Interventions Reports 34% Year-Over-Year Increase in Functional Neurology Revenues, 50% increase in Capital Sales
6.27 Mar 14, 2018: Voyager Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results
6.28 Mar 12, 2018: Neurovascular Embolization Coils and the Potential for Increased Image Artifact When Using Magnetic Resonance Angiography for Follow-Up - Letter to Health Care Providers
6.29 Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results
6.30 Feb 28, 2018: Nexstim Financial Statements Release 2017
6.31 Feb 27, 2018: Baylor St. Luke’s Medical Center First in Texas to Offer PulseRider Technology for Minimally Invasive Treatment of Complex Brain Aneurysms
6.32 Feb 27, 2018: Penumbra Reports Fourth Quarter and Full Year 2017 Financial Results
6.33 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017
6.34 Feb 15, 2018: FDA expands treatment window for use of clot retrieval devices in certain stroke patients
6.35 Feb 15, 2018: Stryker’s Trevo Retriever becomes first and only device indicated for treatment up to 24 hours, aligning with new AHA/ASA guidelines
6.36 Feb 13, 2018: International Publications Validate Cog state Technology’s Clinical Value in Detecting Postoperative Cognitive Dysfunction (POCD)
6.37 Feb 13, 2018: Quidel Receives 510(k) Clearance for QuickVue Influenza A+B Test, Assay Meets FDA’s Class II RIDT Requirements
6.38 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.39 Feb 07, 2018: NICE Publishes Technology Appraisal Guidance About Intrabeam Radiotherapy System for Adjuvant Treatment of Early Breast Cancer
6.40 Feb 06, 2018: Waterpik Releases New Whitening Water Flosser
6.41 Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017
6.42 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.43 Jan 31, 2018: Voyager Therapeutics Announces CEO Succession Plan for 2018
6.44 Jan 30, 2018: Endocuff Vision Significantly Improves Adenoma Detection Rate and Colorectal Cancer Detection During Colonoscopy in Bowel Cancer Screening Patients
6.45 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.46 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook
6.47 Jan 26, 2018: Stryker's WEAVE Trial demonstrates positive results of endovascular treatment for patients with intracranial atherosclerotic disease
6.48 Jan 25, 2018: Aspiration First Approach with Penumbra System Demonstrates Favorable Outcomes for Acute Ischemic Stroke
6.49 Jan 25, 2018: Independent Study Reaffirms Penumbra Aspiration as Frontline Thrombectomy Approach for Acute Ischemic Stroke
6.50 Jan 25, 2018: Stryker’s DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association
6.51 Jan 25, 2018: New Study Shows Use Of EMBOTRAP Device Clot Retriever During Treatment Of Stroke Yields Positive Rates Of Revascularization
6.52 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.53 Jan 24, 2018: MRI Interventions Recognizes FDA Clearance of Voyager’s Investigational New Drug Application for VY-AADC Allowing its Pivotal Program to Begin for Advanced Parkinson’s Disease
6.54 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results
6.55 Jan 19, 2018: School of Engineering awarded two ERC Consolidator Grants
6.56 Jan 17, 2018: Penumbra Announces Key Events at International Stroke Conference 2018 Meeting
6.57 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move
6.58 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.59 Jan 09, 2018: Stryker provides 2017 preliminary net sales results
6.60 Jan 08, 2018: MicroPort NeuroTech Attends CINS 2017
6.61 Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue
6.62 Jan 03, 2018: MRI Interventions ClearPoint Neuro Navigation System Utilized for the First Time in Minnesota
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Interventional Neurology Devices - Pipeline Products by Stage of Development
Table 2: Interventional Neurology Devices - Pipeline Products by Segment
Table 3: Interventional Neurology Devices - Pipeline Products by Territory
Table 4: Interventional Neurology Devices - Pipeline Products by Regulatory Path
Table 5: Interventional Neurology Devices - Pipeline Products by Estimated Approval Date
Table 6: Interventional Neurology Devices - Ongoing Clinical Trials
Table 7: Interventional Neurology Devices Companies - Pipeline Products by Stage of Development
Table 8: Interventional Neurology Devices - Pipeline Products by Stage of Development
Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Alcyone Microcatheter - Product Status
Table 11: Alcyone Microcatheter - Product Description
Table 12: Amnis Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Golden Retriever - Product Status
Table 14: Golden Retriever - Product Description
Table 15: Anaconda BioMed SL Pipeline Products & Ongoing Clinical Trials Overview
Table 16: ANCD BRAIN - Product Status
Table 17: ANCD BRAIN - Product Description
Table 18: Aneuclose LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Janjua Aneurysm Net - Product Status
Table 20: Janjua Aneurysm Net - Product Description
Table 21: Janjua Aneurysm Occlusion Saddle - Product Status
Table 22: Janjua Aneurysm Occlusion Saddle - Product Description
Table 23: Aneuvas Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: PPODA-QT - Product Status
Table 25: PPODA-QT - Product Description
Table 26: Apeliotus Technologies Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Polymer Stent for Cerebral Aneurysms - Product Status
Table 28: Polymer Stent for Cerebral Aneurysms - Product Description
Table 29: Arterain Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Catheter Based System - Product Status
Table 31: Catheter Based System - Product Description
Table 32: Avantec Vascular Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Endovascular Embolization Device - Product Status
Table 34: Endovascular Embolization Device - Product Description
Table 35: Ischemic Stroke Therapy Device - Product Status
Table 36: Ischemic Stroke Therapy Device - Product Description
Table 37: Bendit Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Bendit 2.0 - Product Status
Table 39: Bendit 2.0 - Product Description
Table 40: BioCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: GelCoil - Product Status
Table 42: GelCoil - Product Description
Table 43: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Intracranial Multilayer Flow Modulator - Product Status
Table 45: Intracranial Multilayer Flow Modulator - Product Description
Table 46: Ceretrieve Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Device - Ischemic Stroke - Product Status
Table 48: Device - Ischemic Stroke - Product Description
Table 49: Cerus Endovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Contour Neurovascular System - Product Status
Table 51: Contour Neurovascular System - Product Description
Table 52: NEQSTENT Intra-Saccular Stent - Product Status
Table 53: NEQSTENT Intra-Saccular Stent - Product Description
Table 54: Cerus Endovascular Ltd - Ongoing Clinical Trials Overview
Table 55: Contour Neurovascular System - A Safety Study of the Contour Neurovascular System in Treating Unruptured Aneurysms
Table 56: Codman & Shurtleff Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Covered Stent - Product Status
Table 58: Covered Stent - Product Description
Table 59: Flow Diverter - Product Status
Table 60: Flow Diverter - Product Description
Table 61: Next Generation Balloon Expandable Stent - Product Status
Table 62: Next Generation Balloon Expandable Stent - Product Description
Table 63: Occlusion Balloon - Product Status
Table 64: Occlusion Balloon - Product Description
Table 65: Self-Expanding Stent - Product Status
Table 66: Self-Expanding Stent - Product Description
Table 67: Collagen Matrix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Collagen-based Coils - Product Status
Table 69: Collagen-based Coils - Product Description
Table 70: CranioVation Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Brain Aneurysm Clip - Product Status
Table 72: Brain Aneurysm Clip - Product Description
Table 73: CVTec Cerebrovascular Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 74: CoilAlarm - Product Status
Table 75: CoilAlarm - Product Description
Table 76: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview
Table 77: Aneurysm Clip Applicator - Product Status
Table 78: Aneurysm Clip Applicator - Product Description
Table 79: Cerebral Aneurysm Clip - Product Status
Table 80: Cerebral Aneurysm Clip - Product Description
Table 81: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Liquid Embolic System - Product Status
Table 83: Liquid Embolic System - Product Description
Table 84: EchoGuide Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Ultrasound Catheter Navigation Device - Product Status
Table 86: Ultrasound Catheter Navigation Device - Product Description
Table 87: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview
Table 88: e-Dura Implant - Product Status
Table 89: e-Dura Implant - Product Description
Table 90: Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 91: eCLIPs System - Product Status
Table 92: eCLIPs System - Product Description
Table 93: Evasc Medical Systems Corp - Ongoing Clinical Trials Overview
Table 94: eCLIPs System - A Multi-center Post Marketing Study Evaluating the Safety, Technical Feasibility, and Efficacy of the eCLIPs Family of Products for the Treatment of Bifurcation Intracranial Aneurysms
Table 95: Gaudi Vascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 96: Intracranial Stent - Product Status
Table 97: Intracranial Stent - Product Description
Table 98: Hansen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Magellan Robotic System - Neurological Procedures - Product Status
Table 100: Magellan Robotic System - Neurological Procedures - Product Description
Table 101: Hibernia Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Hybernia Safety Catheter - Neuroprotection - Product Status
Table 103: Hybernia Safety Catheter - Neuroprotection - Product Description
Table 104: Insera Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 105: SHELTER - Product Status
Table 106: SHELTER - Product Description
Table 107: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 108: NGuard Neurovascular - Product Status
Table 109: NGuard Neurovascular - Product Description
Table 110: Instent SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 111: Smart Guide - Product Status
Table 112: Smart Guide - Product Description
Table 113: Medikit Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 114: Aspirarecath - Product Status
Table 115: Aspirarecath - Product Description
Table 116: Axcelguide - Product Status
Table 117: Axcelguide - Product Description
Table 118: Cerulean G - Product Status
Table 119: Cerulean G - Product Description
Table 120: Slimguide - Product Status
Table 121: Slimguide - Product Description
Table 122: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 123: Artisse Intrasaccular Device - Product Status
Table 124: Artisse Intrasaccular Device - Product Description
Table 125: Lazarus Cover - Product Status
Table 126: Lazarus Cover - Product Description
Table 127: Medina Embolization Device - Product Status
Table 128: Medina Embolization Device - Product Description
Table 129: Pipeline Flex w/Shield - Surface Enhancement - Product Status
Table 130: Pipeline Flex w/Shield - Surface Enhancement - Product Description
Table 131: Medtronic plc - Ongoing Clinical Trials Overview
Table 132: Artisse Intrasaccular Device - ARTISSE Aneurysm Treatment Using Intrasaccular Flow Diversion with the ARTISSE Device
Table 133: Medina Embolization Device - Medina Embolization Device in Neurovascular Aneurysms Study - A Post Market Clinical Follow-up Study: The MEDINA Study
Table 134: Merlin MD Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 135: Next Generation Device For Cerebral Aneurysm - Product Status
Table 136: Next Generation Device For Cerebral Aneurysm - Product Description
Table 137: Metactive Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 138: Ballstent Microcatheter - Product Status
Table 139: Ballstent Microcatheter - Product Description
Table 140: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 141: Clot Retrieval Device - Product Status
Table 142: Clot Retrieval Device - Product Description
Table 143: Embolization Coils - Product Status
Table 144: Embolization Coils - Product Description
Table 145: Micro-Catheter - Product Status
Table 146: Micro-Catheter - Product Description
Table 147: Vertebral Artery Rapamycin Target Eluting Stent System - Product Status
Table 148: Vertebral Artery Rapamycin Target Eluting Stent System - Product Description
Table 149: MicroPort Scientific Corp - Ongoing Clinical Trials Overview
Table 150: Embolization Coils - Prospective, Randomized, Controlled, Open Label, All China, Multi-center, Registration Trial of the Microport Neurotech Coil Embolization System for the Treatment of Intracranial Aneurysms
Table 151: MicroVention Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 152: Advanced Coil - Product Status
Table 153: Advanced Coil - Product Description
Table 154: Advanced WEB Aneurysm Embolization Device - Product Status
Table 155: Advanced WEB Aneurysm Embolization Device - Product Description
Table 156: Coated Stent - Product Status
Table 157: Coated Stent - Product Description
Table 158: ERIC Retrieval Device - Product Status
Table 159: ERIC Retrieval Device - Product Description
Table 160: FRED Flow-Diverting Stent - Product Status
1.2 List of Figures
Figure 1: Interventional Neurology Devices - Pipeline Products by Stage of Development
Figure 2: Interventional Neurology Devices - Pipeline Products by Segment
Figure 3: Interventional Neurology Devices - Pipeline Products by Territory
Figure 4: Interventional Neurology Devices - Pipeline Products by Regulatory Path
Figure 5: Interventional Neurology Devices - Pipeline Products by Estimated Approval Date
Figure 6: Interventional Neurology Devices - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report